For the year ending 2025-12-31, UTHR made $3,182,700K in revenue. $1,334,700K in net income. Net profit margin of 41.94%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Total revenues | 3,182,700 | |||
| Cost of sales | 384,400 | |||
| Research and development | 550,000 | |||
| Selling, general, and administrative | 755,800 | |||
| Total operating expenses | 1,690,200 | |||
| Operating income | 1,492,500 | |||
| Interest income | 192,000 | |||
| Interest expense | 19,500 | |||
| Other income (expense), net | 48,900 | |||
| Total other income, net | 221,400 | |||
| Income before income taxes | 1,713,900 | |||
| Income tax expense | 379,200 | |||
| Net income | 1,334,700 | |||
| Basic EPS | 30.13 | |||
| Diluted EPS | 27.86 | |||
| Basic Average Shares | 44,300,000 | |||
| Diluted Average Shares | 47,900,000 | |||
UNITED THERAPEUTICS Corp (UTHR)
UNITED THERAPEUTICS Corp (UTHR)